Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

No effective treatment for hair loss after childbirth was found, but it usually gets better on its own and some cosmetic methods might help.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Long COVID causes various long-term health issues and needs better awareness and treatment.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

Indian men have 62.1% hair loss, mostly grade II vertex, and less extensive than other populations.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Mice with human chymase had a higher death rate when exposed to a toxin compared to normal mice.

ADAM17 could be a potential target for treating PCOS.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

Off-pump heart surgery reduces complications without affecting survival rates compared to on-pump surgery.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

The Rotterdam Study aims to understand various diseases in older adults.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.